Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.27 trillion and total revenue of $117.12 billion.
Market Cap
1.27T
Revenue
117.12B
Profits
-35.3B
PE Ratio
n/a
Profit Margin
-30.14%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 135.64B | 2.03% | 1,641,551 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 81.79B | 1.67% | 852,233 | 15.53B |
| 3 | MRNA | Moderna, Inc. | 80.90B | -17.57% | 49,995,068 | 2.23B |
| 4 | ARGX | argenx SE | 54.89B | -1.61% | 1,020,770 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 43.46B | -1.08% | 359,351 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 40.23B | -3.39% | 1,485,089 | - |
| 7 | RPRX | Royalty Pharma plc | 36.66B | 2.57% | 2,808,458 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.41B | 0.97% | 2,212,202 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 27.05B | 1.77% | 13,451,943 | 7.53M |
| 10 | GMAB | Genmab A/S | 23.76B | 1.09% | 4,685,572 | 4.13B |
| 11 | INCY | Incyte Corporation | 23.70B | 3.08% | 2,236,051 | 5.82B |
| 12 | BNTX | BioNTech SE | 22.53B | -1.77% | 1,146,184 | 3.03B |
| 13 | INSM | Insmed Incorporated | 20.76B | 1.08% | 3,099,480 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 16.18B | 1.13% | 1,710,316 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 15.96B | 1.71% | 539,136 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 14.14B | -0.23% | 5,097,450 | 1.66B |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 13.93B | 1.26% | 783,793 | 4.60B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.32B | 0.56% | 2,780,398 | 713.07M |
| 19 | SMMT | Summit Therapeutics Inc. | 12.44B | -1.77% | 4,150,760 | - |
| 20 | CORT | Corcept Therapeutics Incorporated | 11.62B | -7.55% | 737,285 | 830.81M |
| 21 | TECH | Bio-Techne Corporation | 11.39B | -0.03% | 4,161,605 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.96B | 2.57% | 2,396,853 | 3.41B |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.47B | -1.01% | 212,688 | 1.28B |
| 24 | PCVX | Vaxcyte, Inc. | 9.89B | -0.60% | 2,771,275 | - |
| 25 | KRYS | Krystal Biotech, Inc. | 9.48B | -0.63% | 245,132 | 440.48M |
| 26 | KYMR | Kymera Therapeutics, Inc. | 9.22B | -1.58% | 850,254 | 105.00M |
| 27 | PTGX | Protagonist Therapeutics, Inc. | 9.03B | 1.05% | 404,382 | 281.99M |
| 28 | CAI | Caris Life Sciences, Inc. | 8.96B | -1.98% | 2,422,785 | 989.61M |
| 29 | IBRX | ImmunityBio, Inc. | 8.81B | -3.82% | 12,735,648 | 165.79M |
| 30 | CYTK | Cytokinetics, Incorporated | 8.67B | -0.84% | 2,061,177 | 67.67M |
| 31 | SYRE | Spyre Therapeutics, Inc. | 8.63B | -0.67% | 802,946 | - |
| 32 | TWST | Twist Bioscience Corporation | 8.49B | -9.16% | 2,691,591 | 431.80M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.24B | -0.82% | 1,036,454 | 669.50M |
| 34 | AXSM | Axsome Therapeutics, Inc. | 8.18B | -0.15% | 832,343 | 776.57M |
| 35 | ABVX | ABIVAX Société Anonyme | 7.98B | -3.49% | 896,113 | 5.33M |
| 36 | TGTX | TG Therapeutics, Inc. | 7.54B | -0.08% | 1,289,120 | 799.54M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.30B | -0.81% | 5,011,922 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 7.23B | 0.96% | 355,672 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.41B | -3.28% | 10,769,802 | 324.97M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.26B | 2.57% | 516,393 | 239.92M |
| 41 | LGND | Ligand Pharmaceuticals Incorporated | 6.14B | -2.21% | 315,128 | 290.54M |
| 42 | BLTE | Belite Bio, Inc | 6.05B | -1.90% | 125,652 | - |
| 43 | IMVT | Immunovant, Inc. | 6.01B | 2.54% | 1,157,165 | - |
| 44 | MANE | Veradermics, Incorporated | 5.79B | 1.34% | 794,348 | - |
| 45 | CGON | CG Oncology, Inc. | 5.54B | 0.55% | 579,516 | 6.23M |
| 46 | COGT | Cogent Biosciences, Inc. | 5.43B | -0.38% | 1,178,290 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 5.40B | -0.41% | 420,914 | 618.07M |
| 48 | KOD | Kodiak Sciences Inc. | 5.38B | -2.21% | 592,747 | - |
| 49 | ORKA | Oruka Therapeutics, Inc. | 5.37B | 1.54% | 589,923 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.26B | 0.67% | 674,946 | 1.01B |
| 51 | SRRK | Scholar Rock Holding Corporation | 5.11B | -2.42% | 1,133,533 | - |
| 52 | TVTX | Travere Therapeutics, Inc. | 4.94B | -0.29% | 1,774,177 | 591.33M |
| 53 | ERAS | Erasca, Inc. | 4.91B | -3.11% | 2,295,979 | - |
| 54 | DFTX | Definium Therapeutics, Inc. | 4.84B | 1.44% | 2,112,504 | - |
| 55 | CRSP | CRISPR Therapeutics AG | 4.83B | -1.01% | 905,678 | 13.39M |
| 56 | TNGX | Tango Therapeutics, Inc. | 4.71B | 3.52% | 5,963,156 | 53.81M |
| 57 | DNTH | Dianthus Therapeutics, Inc. | 4.39B | 0.61% | 1,480,220 | 1.90M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.34B | 0.86% | 1,337,723 | - |
| 59 | ARQT | Arcutis Biotherapeutics, Inc. | 4.05B | 1.04% | 2,075,747 | 463.98M |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.02B | -0.38% | 1,721,972 | 10.35M |
| 61 | ABCL | AbCellera Biologics Inc. | 3.68B | -7.11% | 4,277,110 | 66.17M |
| 62 | LEGN | Legend Biotech Corporation | 3.66B | 1.45% | 1,197,787 | 1.27B |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.53B | 1.53% | 1,375,502 | 7.50M |
| 64 | ACAD | Acadia Pharmaceuticals Inc. | 3.50B | 0.59% | 1,229,378 | 1.14B |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.49B | 1.83% | 603,063 | 234.13M |
| 66 | IRON | Disc Medicine, Inc. | 3.33B | -1.28% | 1,585,524 | - |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.33B | -3.34% | 926,144 | 148.00K |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.26B | -4.89% | 734,013 | 890.79M |
| 69 | CELC | Celcuity Inc. | 3.21B | 6.51% | 1,932,771 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.16B | 2.24% | 688,649 | 606.33M |
| 71 | ELVN | Enliven Therapeutics, Inc. | 3.07B | 0.26% | 2,324,851 | - |
| 72 | VKTX | Viking Therapeutics, Inc. | 3.01B | -2.08% | 3,530,547 | - |
| 73 | DNLI | Denali Therapeutics Inc. | 2.98B | -0.11% | 816,743 | 3.60M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.94B | -1.87% | 2,052,545 | - |
| 75 | NRIX | Nurix Therapeutics, Inc. | 2.79B | -1.96% | 1,933,847 | 701.94M |
| 76 | VRDN | Viridian Therapeutics, Inc. | 2.59B | -0.83% | 1,545,890 | 71.13M |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 2.58B | 0.42% | 1,703,250 | 7.12M |
| 78 | ZLAB | Zai Lab Limited | 2.47B | -8.93% | 1,438,905 | 449.61M |
| 79 | RCUS | Arcus Biosciences, Inc. | 2.47B | 1.36% | 8,370,960 | 117.00M |
| 80 | BEAM | Beam Therapeutics Inc. | 2.45B | -1.13% | 1,384,743 | 156.04M |
| 81 | ADMA | ADMA Biologics, Inc. | 2.45B | -0.54% | 3,551,452 | 512.28M |
| 82 | MBX | MBX Biosciences, Inc. | 2.43B | -6.43% | 631,689 | - |
| 83 | AUPH | Aurinia Pharmaceuticals Inc. | 2.31B | 2.54% | 780,426 | 311.51M |
| 84 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -6.51% | 6,512,781 | - |
| 85 | PGEN | Precigen, Inc. | 2.29B | -3.18% | 6,253,831 | 85.72M |
| 86 | CLDX | Celldex Therapeutics, Inc. | 2.28B | -1.36% | 877,930 | 158.00K |
| 87 | FTRE | Fortrea Holdings Inc. | 2.27B | -0.58% | 1,986,926 | 2.68B |
| 88 | AGIO | Agios Pharmaceuticals, Inc. | 2.22B | 0.03% | 931,099 | 98.34M |
| 89 | BHVN | Biohaven Ltd. | 2.22B | 25.02% | 30,510,497 | - |
| 90 | VCEL | Vericel Corporation | 2.20B | 4.96% | 604,931 | 306.30M |
| 91 | PHVS | Pharvaris N.V. | 2.15B | -0.16% | 347,233 | - |
| 92 | RXRX | Recursion Pharmaceuticals, Inc. | 2.14B | -1.65% | 17,735,730 | 54.86M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 2.10B | -5.95% | 2,905,188 | 959.90M |
| 94 | VERA | Vera Therapeutics, Inc. | 2.09B | -6.89% | 2,545,668 | - |
| 95 | IMNM | Immunome, Inc. | 2.07B | 1.44% | 1,761,577 | 4.02M |
| 96 | ZYME | Zymeworks Inc. | 2.02B | 1.14% | 757,276 | 37.13M |
| 97 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | 3.21% | 181,458 | 6.13M |
| 98 | LKFT | Lakefront Biotherapeutics NV | 1.98B | 2.68% | 307,945 | 1.13B |
| 99 | XNCR | Xencor, Inc. | 1.92B | 2.70% | 936,276 | 104.97M |
| 100 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | -2.05% | 1,235,359 | 1.97B |
| 101 | SEPN | Septerna, Inc. | 1.91B | 0.29% | 251,074 | 98.88M |
| 102 | MLYS | Mineralys Therapeutics, Inc. | 1.90B | 1.75% | 824,729 | - |
| 103 | TRVI | Trevi Therapeutics, Inc. | 1.84B | 1.33% | 1,184,910 | - |
| 104 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 0.68% | 406,012 | 1.00M |
| 105 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.84B | -6.61% | 3,920,255 | 208.78M |
| 106 | PVLA | Palvella Therapeutics, Inc. | 1.82B | -0.15% | 104,398 | - |
| 107 | MAZE | Maze Therapeutics, Inc. | 1.77B | -1.93% | 891,547 | 20.00M |
| 108 | VIR | Vir Biotechnology, Inc. | 1.76B | -1.32% | 987,074 | 303.23M |
| 109 | BRVE | Braveheart Bio, Inc. | 1.75B | 2.09% | 156,502 | - |
| 110 | KLRA | Kailera Therapeutics, Inc. | 1.72B | 2.71% | 855,721 | - |
| 111 | URGN | UroGen Pharma Ltd. | 1.72B | -0.93% | 689,100 | 188.73M |
| 112 | MESO | Mesoblast Limited | 1.67B | -2.18% | 236,781 | 120.25M |
| 113 | STOK | Stoke Therapeutics, Inc. | 1.66B | 0.08% | 1,346,388 | 27.59M |
| 114 | IMCR | Immunocore Holdings plc | 1.65B | 0.09% | 283,249 | 430.78M |
| 115 | NUVB | Nuvation Bio Inc. | 1.65B | -3.09% | 5,805,180 | 169.90M |
| 116 | NVAX | Novavax, Inc. | 1.65B | -9.26% | 12,238,865 | 413.80M |
| 117 | GENB | Generate Biomedicines, Inc. | 1.64B | -2.44% | 498,911 | 26.48M |
| 118 | COAG | Hemab Therapeutics Holdings, Inc. | 1.63B | -1.36% | 368,982 | - |
| 119 | ABSI | Absci Corporation | 1.61B | -6.67% | 3,706,661 | 1.56M |
| 120 | QURE | uniQure N.V. | 1.60B | 1.85% | 1,546,358 | 18.67M |
| 121 | RARE | Ultragenyx Pharmaceutical Inc. | 1.57B | 0.19% | 2,374,049 | 717.00M |
| 122 | GPCR | Structure Therapeutics Inc. | 1.56B | -0.36% | 702,324 | - |
| 123 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -4.21% | 3,650,772 | 59.51M |
| 124 | TRAX | First Tracks Biotherapeutics, Inc. | 1.54B | 0.87% | 844,273 | - |
| 125 | KRSA | Korsana Biosciences, Inc. | 1.52B | 2.74% | 93,069 | - |
| 126 | INVA | Innoviva, Inc. | 1.52B | 0.72% | 452,066 | 440.00M |
| 127 | NBTX | Nanobiotix S.A. | 1.48B | 13.01% | 216,509 | 13.15M |
| 128 | OCUL | Ocular Therapeutix, Inc. | 1.45B | 2.01% | 2,145,005 | 52.06M |
| 129 | ANAB | AnaptysBio, Inc. | 1.44B | 0.33% | 254,904 | 106.09M |
| 130 | TYRA | Tyra Biosciences, Inc. | 1.43B | 1.31% | 826,145 | - |
| 131 | INBX | Inhibrx Biosciences, Inc. | 1.43B | -1.11% | 249,508 | 1.30M |
| 132 | ORIC | ORIC Pharmaceuticals, Inc. | 1.41B | -1.59% | 1,150,442 | - |
| 133 | DMRA | Damora Therapeutics, Inc. | 1.34B | 0.84% | 420,640 | - |
| 134 | AAPG | Ascentage Pharma Group International | 1.34B | -8.69% | 18,788 | 94.61M |
| 135 | NKTR | Nektar Therapeutics | 1.32B | 0.99% | 1,022,166 | 54.59M |
| 136 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -2.79% | 3,105,090 | 5.49M |
| 137 | RAPP | Rapport Therapeutics, Inc. | 1.27B | 5.87% | 1,459,439 | 20.00M |
| 138 | LBRX | LB Pharmaceuticals Inc | 1.27B | 0.48% | 230,853 | - |
| 139 | GHRS | GH Research PLC | 1.27B | -2.17% | 329,102 | - |
| 140 | VSTM | Verastem, Inc. | 1.22B | 9.23% | 5,947,039 | 87.53M |
| 141 | OMER | Omeros Corporation | 1.22B | 3.69% | 737,274 | 38.42M |
| 142 | SNDX | Syndax Pharmaceuticals, Inc. | 1.21B | 3.19% | 2,362,680 | 252.25M |
| 143 | AVLN | Avalyn Pharma Inc. | 1.21B | 9.08% | 286,743 | - |
| 144 | KARD | Kardigan, Inc. | 1.19B | -0.86% | 380,787 | - |
| 145 | DRTS | Alpha Tau Medical Ltd. | 1.19B | -4.30% | 447,629 | - |
| 146 | SLN | Silence Therapeutics plc | 1.18B | -0.05% | 3,078,637 | 615.00K |
| 147 | BCAX | Bicara Therapeutics Inc. | 1.17B | -1.68% | 816,891 | - |
| 148 | SVRA | Savara Inc. | 1.15B | -2.78% | 2,709,761 | - |
| 149 | REPL | Replimune Group, Inc. | 1.13B | 2.30% | 1,760,788 | - |
| 150 | VOR | Vor Biopharma Inc. | 1.12B | - | 723,515 | - |
| 151 | SPTX | Seaport Therapeutics, Inc. | 1.11B | 5.52% | 131,419 | - |
| 152 | LTGO | Latigo Biotherapeutics, Inc. | 1.10B | 1.41% | 119,376 | - |
| 153 | MLTX | MoonLake Immunotherapeutics | 1.05B | 15.87% | 6,120,090 | - |
| 154 | JANX | Janux Therapeutics, Inc. | 1.04B | 0.77% | 514,246 | 24.00M |
| 155 | CTY | City Therapeutics, Inc. | 1.03B | 1.66% | 127,586 | 14.34M |
| 156 | IMTX | Immatics N.V. | 1.03B | -1.95% | 621,016 | 47.65M |
| 157 | MNKD | MannKind Corporation | 1.03B | 4.92% | 3,252,267 | 393.63M |
| 158 | CGEM | Cullinan Therapeutics, Inc. | 960.17M | 0.20% | 392,651 | - |
| 159 | JBIO | Jade Biosciences, Inc. | 948.24M | -1.45% | 575,925 | - |
| 160 | GLUE | Monte Rosa Therapeutics, Inc. | 947.83M | -0.98% | 1,284,512 | 28.73M |
| 161 | AVBP | ArriVent BioPharma, Inc. | 946.71M | 0.42% | 843,599 | - |
| 162 | SGP | SpyGlass Pharma, Inc. | 943.90M | 1.77% | 91,317 | - |
| 163 | MGTX | MeiraGTx Holdings plc | 938.34M | -0.91% | 471,917 | 397.50M |
| 164 | AKTS | Aktis Oncology, Inc. | 932.18M | 2.07% | 186,963 | 10.06M |
| 165 | ODTX | Odyssey Therapeutics, Inc. | 914.28M | 0.42% | 141,753 | 99.00K |
| 166 | RIGL | Rigel Pharmaceuticals, Inc. | 912.70M | -0.04% | 152,639 | 276.79M |
| 167 | CRVS | Corvus Pharmaceuticals, Inc. | 895.89M | 5.97% | 1,080,556 | - |
| 168 | ALMS | Alumis Inc. | 882.75M | 0.15% | 1,503,406 | 7.40M |
| 169 | KURA | Kura Oncology, Inc. | 877.15M | -0.20% | 1,061,865 | 77.23M |
| 170 | ANRO | Alto Neuroscience, Inc. | 871.17M | -4.80% | 510,817 | - |
| 171 | OBX | Obsidian Therapeutics, Inc. | 861.11M | 0.07% | 174,494 | - |
| 172 | ABUS | Arbutus Biopharma Corporation | 832.94M | 0.72% | 2,464,086 | 181.72M |
| 173 | IVA | Inventiva S.A. | 821.92M | 1.41% | 2,399,497 | 2.81M |
| 174 | ARDX | Ardelyx, Inc. | 797.40M | 2.24% | 2,723,800 | 450.89M |
| 175 | APMD | Apnimed, Inc. | 771.42M | -1.96% | 194,811 | 115.12M |
| 176 | HELP | Helus Pharma Inc. | 767.13M | -2.60% | 1,915,947 | - |
| 177 | PHAR | Pharming Group N.V. | 748.06M | 10.57% | 21,600 | 366.48M |
| 178 | SLBT | SL Science Holding Limited | 747.05M | -9.66% | 32,000 | 3.27M |
| 179 | GERN | Geron Corporation | 725.99M | -2.59% | 7,178,600 | 204.56M |
| 180 | ANNX | Annexon, Inc. | 722.30M | -1.30% | 3,665,144 | - |
| 181 | SANA | Sana Biotechnology, Inc. | 709.48M | 0.85% | 2,429,258 | - |
| 182 | SGMT | Sagimet Biosciences Inc. | 705.54M | -0.40% | 1,006,778 | - |
| 183 | IAM | Iambic Therapeutics, Inc. | 695.37M | -7.15% | 497,477 | 18.25M |
| 184 | OABI | OmniAb, Inc. | 694.97M | -2.75% | 1,336,419 | 38.46M |
| 185 | IMMX | Immix Biopharma, Inc. | 692.24M | -1.88% | 817,855 | - |
| 186 | ANL | Adlai Nortye Group Ltd. | 681.33M | -6.04% | 169,967 | 18.06M |
| 187 | NVCT | Nuvectis Pharma, Inc. | 680.63M | 1.35% | 110,051 | - |
| 188 | AURA | Aura Biosciences, Inc. | 669.93M | - | 955,315 | - |
| 189 | ACHV | Achieve Life Sciences, Inc. | 668.87M | -0.15% | 963,280 | - |
| 190 | SLDB | Solid Biosciences Inc. | 663.72M | -3.43% | 1,217,087 | - |
| 191 | PRME | Prime Medicine, Inc. | 663.58M | -2.10% | 4,657,478 | 4.07M |
| 192 | LXRX | Lexicon Pharmaceuticals, Inc. | 662.98M | -4.49% | 1,320,435 | 41.47M |
| 193 | ATTO | Attovia Therapeutics, Inc. | 661.94M | 2.26% | 189,144 | 1.80M |
| 194 | WVE | Wave Life Sciences, Inc. | 660.11M | -0.59% | 1,847,408 | 65.37M |
| 195 | DSGN | Design Therapeutics, Inc. | 656.48M | -2.24% | 270,712 | - |
| 196 | FDMT | 4D Molecular Therapeutics, Inc. | 654.64M | -6.10% | 1,354,575 | 92.01M |
| 197 | DNA | Ginkgo Bioworks Holdings, Inc. | 653.87M | -3.00% | 1,979,120 | 132.42M |
| 198 | CADL | Candel Therapeutics, Inc. | 641.23M | 0.12% | 762,579 | - |
| 199 | CRMD | CorMedix Inc. | 631.35M | 3.98% | 1,092,071 | 462.25M |
| 200 | GYRE | Gyre Therapeutics, Inc. | 621.36M | -0.85% | 66,575 | 109.82M |
| 201 | OLMA | Olema Pharmaceuticals, Inc. | 614.23M | -0.43% | 1,064,856 | - |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 613.43M | -0.29% | 537,230 | 136.07M |
| 203 | CLYM | Climb Bio, Inc. | 605.38M | -3.04% | 654,057 | - |
| 204 | DBVT | DBV Technologies S.A. | 583.14M | 0.62% | 121,590 | 5.04M |
| 205 | PBYI | Puma Biotechnology, Inc. | 581.24M | 3.30% | 395,518 | 231.24M |
| 206 | ETRA | Electra Therapeutics, Inc. | 580.59M | 2.21% | 155,800 | - |
| 207 | MDXG | MiMedx Group, Inc. | 572.84M | 5.08% | 1,575,764 | 355.17M |
| 208 | ACRS | Aclaris Therapeutics, Inc. | 563.77M | 0.52% | 2,799,134 | 8.22M |
| 209 | CBIO | Crescent Biopharma, Inc. | 562.41M | -0.23% | 163,324 | 11.88M |
| 210 | STTK | Shattuck Labs, Inc. | 562.03M | 0.36% | 1,220,822 | 1.00M |
| 211 | PHAT | Phathom Pharmaceuticals, Inc. | 556.80M | -0.28% | 811,712 | 239.66M |
| 212 | CTMX | CytomX Therapeutics, Inc. | 531.67M | 1.67% | 2,444,640 | 18.30M |
| 213 | ENTX | Entera Bio Ltd. | 525.25M | -0.98% | 629,441 | 42.00K |
| 214 | FTH | Faeth Therapeutics, Inc. | 519.39M | -2.28% | 314,494 | - |
| 215 | DRUG | Bright Minds Biosciences Inc. | 514.32M | 4.46% | 221,304 | - |
| 216 | VALN | Valneva SE | 509.71M | -3.60% | 22,500 | 163.30M |
| 217 | ARVN | Arvinas, Inc. | 504.78M | 2.12% | 620,142 | 316.70M |
| 218 | BLSM | BlossomHill Therapeutics, Inc. | 502.52M | 1.67% | 97,971 | - |
| 219 | EPRX | Eupraxia Pharmaceuticals Inc. | 500.10M | -1.81% | 391,893 | - |
| 220 | OCS | Oculis Holding AG | 499.41M | 2.80% | 427,887 | 1.45M |
| 221 | MNPR | Monopar Therapeutics Inc. | 487.17M | 0.32% | 122,549 | - |
| 222 | NGNE | Neurogene Inc. | 485.88M | -6.90% | 212,365 | 925.00K |
| 223 | RGNX | REGENXBIO Inc. | 473.31M | - | 1,132,499 | 174.48M |
| 224 | DMAC | DiaMedica Therapeutics Inc. | 465.38M | -0.69% | 87,987 | - |
| 225 | OVID | Ovid Therapeutics Inc. | 462.86M | -4.05% | 1,177,574 | 1.58M |
| 226 | INDP | Indaptus Therapeutics, Inc. | 459.21M | -5.38% | 224,169 | - |
| 227 | MPLT | MapLight Therapeutics, Inc. | 458.50M | 1.10% | 349,512 | - |
| 228 | AGMB | AgomAb Therapeutics NV | 456.04M | 1.65% | 84,321 | - |
| 229 | SRZN | Surrozen, Inc. | 450.50M | 1.70% | 137,022 | 11.51M |
| 230 | EIKN | Eikon Therapeutics, Inc. | 446.32M | 3.00% | 348,516 | - |
| 231 | PROK | ProKidney Corp. | 432.32M | -0.69% | 584,476 | 818.00K |
| 232 | ALLO | Allogene Therapeutics, Inc. | 431.86M | -6.02% | 8,296,760 | 4.64M |
| 233 | SPRY | ARS Pharmaceuticals, Inc. | 429.61M | 3.35% | 1,787,743 | 116.93M |
| 234 | PRTA | Prothena Corporation plc | 423.53M | 2.62% | 381,827 | 54.53M |
| 235 | ALT | Altimmune, Inc. | 422.10M | -2.69% | 3,094,225 | 31.00K |
| 236 | AUTL | Autolus Therapeutics plc | 420.54M | -2.47% | 1,920,107 | 117.39M |
| 237 | TRXB | TRex Bio, Inc. | 417.29M | 1.64% | 67,487 | - |
| 238 | ASMB | Assembly Biosciences, Inc. | 412.91M | -0.78% | 137,849 | 74.85M |
| 239 | TECX | Tectonic Therapeutic, Inc. | 412.30M | -3.43% | 251,375 | - |
| 240 | RZLT | Rezolute, Inc. | 404.90M | 4.32% | 1,355,631 | - |
| 241 | AVTX | Avalo Therapeutics, Inc. | 399.54M | -39.23% | 26,189,975 | 59.00K |
| 242 | CCCC | C4 Therapeutics, Inc. | 391.22M | 0.32% | 1,692,666 | 35.04M |
| 243 | EDIT | Editas Medicine, Inc. | 382.41M | -0.80% | 1,066,476 | 47.01M |
| 244 | PRLD | Prelude Therapeutics Incorporated | 370.78M | -1.37% | 323,753 | 22.42M |
| 245 | FENC | Fennec Pharmaceuticals Inc. | 361.89M | -0.58% | 104,169 | 59.22M |
| 246 | CAPR | Capricor Therapeutics, Inc. | 356.39M | 4.25% | 2,755,066 | 11.13M |
| 247 | KYTX | Kyverna Therapeutics, Inc. | 354.36M | -1.88% | 519,377 | - |
| 248 | RLMD | Relmada Therapeutics, Inc. | 350.94M | 2.49% | 6,281,119 | - |
| 249 | GALT | Galectin Therapeutics Inc. | 340.87M | 0.30% | 161,534 | - |
| 250 | SCTX | Scribe Therapeutics Inc. | 340.01M | -6.94% | 641,300 | 33.30M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 338.44M | 2.74% | 200,623 | 65.26M |
| 252 | ZURA | Zura Bio Limited | 338.28M | -14.53% | 8,812,063 | - |
| 253 | VTVT | vTv Therapeutics Inc. | 337.46M | -2.20% | 10,763 | 36.84M |
| 254 | NAUT | Nautilus Biotechnology, Inc. | 330.86M | -4.06% | 6,911,962 | 190.00K |
| 255 | OBIO | Orchestra BioMed Holdings, Inc. | 328.77M | -5.85% | 390,873 | 31.98M |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 324.83M | -0.74% | 318,738 | - |
| 257 | IRD | Opus Genetics, Inc. | 317.81M | -7.17% | 894,735 | 9.86M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 317.27M | 6.31% | 594,589 | 15.85M |
| 259 | CTNM | Contineum Therapeutics, Inc. | 315.83M | 0.54% | 498,752 | - |
| 260 | BNTC | Benitec Biopharma Inc. | 307.67M | 3.76% | 149,000 | - |
| 261 | ARCT | Arcturus Therapeutics Holdings Inc. | 304.98M | -3.07% | 471,335 | 29.37M |
| 262 | TTRX | Turn Therapeutics Inc. | 303.24M | 0.30% | 113,120 | - |
| 263 | ARTV | Artiva Biotherapeutics, Inc. | 303.12M | -4.47% | 393,893 | 251.00K |
| 264 | YDES | YD Bio Limited | 300.32M | -26.52% | 180,415 | 1.24M |
| 265 | IKT | Inhibikase Therapeutics, Inc. | 296.78M | -1.81% | 310,489 | 1.00 |
| 266 | AGEN | Agenus Inc. | 293.08M | 1.72% | 553,492 | 132.69M |
| 267 | IPSC | Century Therapeutics, Inc. | 286.10M | -1.86% | 1,766,207 | 109.16M |
| 268 | VOGX | Vogenx, Inc. | 283.44M | -6.42% | 90,964 | - |
| 269 | FULC | Fulcrum Therapeutics, Inc. | 280.77M | -0.54% | 2,309,019 | 80.00M |
| 270 | SABS | SAB Biotherapeutics, Inc. | 276.60M | 7.80% | 709,197 | 114.70K |
| 271 | ALEC | Alector, Inc. | 271.31M | -2.14% | 1,480,195 | 13.86M |
| 272 | OCGN | Ocugen, Inc. | 267.90M | -3.08% | 6,718,956 | 4.58M |
| 273 | QTTB | Q32 Bio Inc. | 261.97M | 1.50% | 363,639 | 53.74M |
| 274 | CABA | Cabaletta Bio, Inc. | 257.71M | -1.30% | 2,240,340 | - |
| 275 | ABEO | Abeona Therapeutics Inc. | 255.61M | -0.89% | 717,797 | 25.52M |
| 276 | BCYC | Bicycle Therapeutics plc | 254.77M | 1.96% | 276,237 | 61.21M |
| 277 | RCKT | Rocket Pharmaceuticals, Inc. | 253.58M | 5.00% | 2,163,504 | - |
| 278 | VCRE | Vicore Pharma Holding AB (publ) | 252.00M | 11.21% | 103,112 | 412.09K |
| 279 | FATE | Fate Therapeutics, Inc. | 250.42M | 0.97% | 865,591 | 6.49M |
| 280 | CUVL | Clinuvel Pharmaceuticals Limited | 250.18M | -1.76% | 23,845 | 65.05M |
| 281 | LCTX | Lineage Cell Therapeutics, Inc. | 249.11M | 3.52% | 1,346,738 | 13.08M |
| 282 | ACIU | AC Immune SA | 248.57M | 1.21% | 73,028 | 21.67M |
| 283 | IMRX | Immuneering Corporation | 246.50M | 1.87% | 526,778 | - |
| 284 | VNDA | Vanda Pharmaceuticals Inc. | 244.87M | 1.00% | 604,761 | 215.72M |
| 285 | LXEO | Lexeo Therapeutics, Inc. | 237.10M | -3.67% | 492,467 | - |
| 286 | LRMR | Larimar Therapeutics, Inc. | 236.95M | -6.20% | 1,763,828 | - |
| 287 | PALI | Palisade Bio, Inc. | 235.27M | -3.57% | 1,114,128 | 500.00K |
| 288 | MGNX | MacroGenics, Inc. | 231.23M | 1.11% | 465,520 | 175.14M |
| 289 | LYEL | Lyell Immunopharma, Inc. | 229.86M | -0.32% | 93,161 | 27.00K |
| 290 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 228.50M | 6.34% | 661,894 | - |
| 291 | ZNTL | Zentalis Pharmaceuticals, Inc. | 228.16M | 2.12% | 746,225 | 26.87M |
| 292 | GLSI | Greenwich LifeSciences, Inc. | 227.22M | -6.58% | 96,440 | - |
| 293 | IFRX | InflaRx N.V. | 225.47M | -1.29% | 404,202 | -11.54K |
| 294 | KROS | Keros Therapeutics, Inc. | 225.04M | 1.52% | 115,510 | 15.01M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 220.63M | 2.54% | 46,231 | 1.80M |
| 296 | CAMP | Camp4 Therapeutics Corporation | 212.73M | 3.04% | 141,125 | 4.22M |
| 297 | PLX | Protalix BioTherapeutics, Inc. | 207.07M | - | 457,114 | 80.62M |
| 298 | PYXS | Pyxis Oncology, Inc. | 204.27M | -2.84% | 557,502 | 11.04M |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 193.94M | 0.16% | 89,199 | 1.48M |
| 300 | EVMN | Evommune, Inc. | 189.08M | 0.77% | 255,756 | 10.00M |
| 301 | PRQR | ProQR Therapeutics N.V. | 187.69M | -2.92% | 566,810 | 21.05M |
| 302 | DTIL | Precision BioSciences, Inc. | 187.14M | 1.04% | 132,426 | 45.06M |
| 303 | ELDN | Eledon Pharmaceuticals, Inc. | 187.09M | 1.77% | 526,637 | - |
| 304 | PEPG | PepGen Inc. | 187.00M | -0.74% | 1,041,830 | - |
| 305 | CGEN | Compugen Ltd. | 185.66M | -7.55% | 283,400 | 74.00M |
| 306 | WHWK | Whitehawk Therapeutics, Inc. | 185.28M | -1.07% | 261,701 | 7.15M |
| 307 | YARW | Yarrow Bioscience, Inc. | 182.37M | -2.83% | 143,779 | - |
| 308 | ACOG | Alpha Cognition Inc. | 180.97M | -3.15% | 214,002 | 15.26M |
| 309 | IVVD | Invivyd, Inc. | 179.83M | -4.57% | 4,317,062 | 58.37M |
| 310 | KRRO | Korro Bio, Inc. | 177.44M | 29.71% | 476,465 | 2.38M |
| 311 | SION | Sionna Therapeutics, Inc. | 171.81M | -1.81% | 1,592,030 | - |
| 312 | ORMP | Oramed Pharmaceuticals Inc. | 171.38M | -0.48% | 97,611 | 2.00M |
| 313 | STRO | Sutro Biopharma, Inc. | 170.62M | -4.63% | 292,840 | 45.70M |
| 314 | TRDA | Entrada Therapeutics, Inc. | 170.55M | 1.72% | 462,051 | 4.69M |
| 315 | ALXO | ALX Oncology Holdings Inc. | 164.55M | 3.48% | 572,813 | - |
| 316 | ADAG | Adagene Inc. | 163.83M | 1.24% | 244,219 | 9.29M |
| 317 | UPB | Upstream Bio, Inc. | 163.77M | 6.79% | 1,450,020 | 3.16M |
| 318 | CHRS | Coherus Oncology, Inc. | 162.23M | 2.94% | 641,906 | 50.94M |
| 319 | MDWD | MediWound Ltd. | 157.25M | 0.66% | 88,640 | 11.86M |
| 320 | NBP | NovaBridge Biosciences | 154.28M | -2.92% | 456,139 | - |
| 321 | NGEN | NervGen Pharma Corp. | 152.68M | -5.33% | 628,422 | - |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 148.97M | 1.48% | 569,418 | - |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 148.21M | -3.63% | 778,221 | 1.50M |
| 324 | VRXA | Veraxa Biotech AG | 145.65M | -2.83% | 171,623 | 29.54K |
| 325 | CMPX | Compass Therapeutics, Inc. | 144.34M | -1.60% | 2,173,538 | 850.00K |
| 326 | TARA | Protara Therapeutics, Inc. | 144.19M | -2.40% | 1,761,523 | - |
| 327 | CDXS | Codexis, Inc. | 142.36M | 0.78% | 501,521 | 77.68M |
| 328 | MOLN | Molecular Partners AG | 140.95M | -2.98% | - | 856.30K |
| 329 | RNA | Atrium Therapeutics, Inc. | 139.58M | 2.00% | 173,479 | 35.84M |
| 330 | MSLE | Satellos Bioscience Inc. | 137.86M | -1.12% | 21,373 | - |
| 331 | ANTX | AN2 Therapeutics, Inc. | 137.36M | 1.11% | 95,190 | - |
| 332 | CUE | Cue Biopharma, Inc. | 137.22M | -0.32% | 54,593 | 37.66M |
| 333 | OTLK | Outlook Therapeutics, Inc. | 137.18M | 0.39% | 4,395,784 | -1.16M |
| 334 | IPHA | Innate Pharma S.A. | 136.89M | -4.46% | 32,699 | 11.21M |
| 335 | SPRB | Spruce Biosciences, Inc. | 132.20M | 7.65% | 126,433 | 697.00K |
| 336 | MENS | Jyong Biotech Ltd. | 129.17M | -7.94% | 130,189 | - |
| 337 | RTSN | Retension Pharmaceuticals, Inc. | 129.14M | 3.33% | 121,131 | - |
| 338 | ARMP | Armata Pharmaceuticals, Inc. | 128.28M | 12.75% | 107,994 | 5.54M |
| 339 | HURA | TuHURA Biosciences, Inc. | 128.09M | -3.60% | 609,256 | - |
| 340 | TLSA | Tiziana Life Sciences Ltd | 128.03M | -0.99% | 493,994 | - |
| 341 | AVXL | Anavex Life Sciences Corp. | 126.07M | - | 1,014,926 | - |
| 342 | NKTX | Nkarta, Inc. | 124.63M | -0.57% | 1,679,824 | - |
| 343 | BDTX | Black Diamond Therapeutics, Inc. | 119.50M | - | 790,924 | 70.00M |
| 344 | FHTX | Foghorn Therapeutics Inc. | 119.36M | -1.47% | 301,050 | 36.74M |
| 345 | HUMA | Humacyte, Inc. | 114.76M | 0.46% | 2,259,301 | 2.12M |
| 346 | VYGR | Voyager Therapeutics, Inc. | 114.61M | -7.92% | 1,299,587 | 34.46M |
| 347 | NERV | Minerva Neurosciences, Inc. | 114.59M | 0.42% | 120,951 | - |
| 348 | KZIA | Kazia Therapeutics Limited | 110.59M | -1.34% | 128,764 | 1.27M |
| 349 | UNCY | Unicycive Therapeutics, Inc. | 109.75M | 1.81% | 742,888 | - |
| 350 | SEER | Seer, Inc. | 109.08M | -2.96% | 106,014 | 14.22M |
| 351 | TVGN | Tevogen Inc. | 107.17M | 5.75% | 35,948 | - |
| 352 | CBUS | Cibus, Inc. | 107.00M | -0.71% | 47,322 | 4.35M |
| 353 | ENGN | enGene Therapeutics Inc. | 105.89M | -3.07% | 554,575 | - |
| 354 | OKUR | OnKure Therapeutics, Inc. | 104.48M | 12.17% | 243,672 | - |
| 355 | PYPD | PolyPid Ltd. | 104.20M | 1.18% | 155,519 | - |
| 356 | NRXP | NRx Pharmaceuticals, Inc. | 103.83M | -8.75% | 1,051,688 | 3.39M |
| 357 | LENZ | LENZ Therapeutics, Inc. | 102.12M | 0.93% | 435,385 | 21.48M |
| 358 | TENX | Tenax Therapeutics, Inc. | 100.82M | 7.98% | 3,299,451 | - |
| 359 | MIST | Milestone Pharmaceuticals Inc. | 99.02M | 1.06% | 621,331 | 2.34M |
| 360 | PMVP | PMV Pharmaceuticals, Inc. | 98.54M | -4.04% | 128,612 | - |
| 361 | IMUX | Immunic, Inc. | 98.51M | -3.48% | 473,360 | - |
| 362 | VANI | Vivani Medical, Inc. | 98.32M | -6.03% | 242,078 | - |
| 363 | COYA | Coya Therapeutics, Inc. | 97.12M | - | 82,987 | 8.02M |
| 364 | PLYX | Polaryx Therapeutics, Inc. | 96.70M | - | 15,568 | - |
| 365 | ANIX | Anixa Biosciences, Inc. | 96.64M | 2.58% | 156,811 | - |
| 366 | NRXS | NeurAxis, Inc. | 95.44M | -4.04% | 86,950 | 5.32M |
| 367 | ICCC | ImmuCell Corporation | 94.82M | -0.76% | 5,772 | 30.68M |
| 368 | ATRA | Atara Biotherapeutics, Inc. | 94.66M | 0.86% | 23,008 | 6.19M |
| 369 | CNXU | Conexeu Sciences Inc. | 93.08M | -0.90% | 207,628 | - |
| 370 | GNLX | Genelux Corporation | 88.73M | -4.35% | 947,444 | 8.00K |
| 371 | TNXP | Tonix Pharmaceuticals Holding Corp. | 87.98M | -5.52% | 905,740 | 29.10M |
| 372 | RLYB | Rallybio Corporation | 87.09M | 1.11% | 5,516 | 646.00K |
| 373 | TNYA | Tenaya Therapeutics, Inc. | 87.00M | -0.56% | 1,721,179 | 1.34M |
| 374 | INO | Inovio Pharmaceuticals, Inc. | 86.74M | 5.48% | 5,519,408 | 65.34K |
| 375 | AARD | Aardvark Therapeutics, Inc. | 86.45M | -10.43% | 1,415,303 | - |
| 376 | PDSB | PDS Biotechnology Corporation | 84.07M | -6.45% | 5,122,577 | - |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 81.91M | -2.88% | 773,552 | 4.88M |
| 378 | PMN | ProMIS Neurosciences, Inc. | 80.53M | -1.64% | 6,438 | - |
| 379 | EQ | Equillium, Inc. | 80.53M | -10.56% | 315,473 | 4.39M |
| 380 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 79.88M | -3.62% | 983,757 | - |
| 381 | OKYO | OKYO Pharma Limited | 77.14M | -3.57% | 72,476 | - |
| 382 | CLLS | Cellectis S.A. | 77.09M | -1.90% | 129,352 | 63.82M |
| 383 | NMRA | Neumora Therapeutics, Inc. | 76.23M | -2.48% | 865,065 | - |
| 384 | ACRV | Acrivon Therapeutics, Inc. | 75.42M | -3.56% | 90,311 | - |
| 385 | PTHS | Pelthos Therapeutics Inc. | 75.00M | 4.76% | 79,803 | 43.30M |
| 386 | TELO | Telomir Pharmaceuticals, Inc. | 74.35M | -0.98% | 94,438 | - |
| 387 | NTHI | NeOnc Technologies Holdings, Inc. | 73.33M | 1.72% | 70,272 | 39.99K |
| 388 | CRDF | Cardiff Oncology, Inc. | 72.19M | -1.17% | 228,676 | 508.00K |
| 389 | NTRB | Nutriband Inc. | 70.62M | -5.37% | 16,711 | 1.62M |
| 390 | MNOV | MediciNova, Inc. | 69.40M | 0.71% | 30,488 | 920.48K |
| 391 | MAIA | MAIA Biotechnology, Inc. | 68.73M | -0.88% | 92,282 | - |
| 392 | CING | Cingulate Inc. | 67.76M | 0.64% | 77,949 | - |
| 393 | CGTX | Cognition Therapeutics, Inc. | 66.62M | -6.16% | 1,017,356 | - |
| 394 | FBIO | Fortress Biotech, Inc. | 66.37M | 2.58% | 183,257 | 68.47M |
| 395 | CSBR | Champions Oncology, Inc. | 66.25M | -1.86% | 16,000 | 60.66M |
| 396 | SPRO | Spero Therapeutics, Inc. | 65.81M | -3.42% | 201,799 | 47.00M |
| 397 | VRCA | Verrica Pharmaceuticals Inc. | 65.79M | 5.51% | 109,867 | 30.32M |
| 398 | ONCY | Oncolytics Biotech Inc. | 63.78M | -2.19% | 406,852 | - |
| 399 | XBIT | XBiotech Inc. | 60.06M | -1.01% | 7,666 | - |
| 400 | CRBU | Caribou Biosciences, Inc. | 60.04M | 2.87% | 2,784,436 | 10.04M |
| 401 | GOSS | Gossamer Bio, Inc. | 57.86M | -3.37% | 188,766 | 53.29M |
| 402 | OSTX | OS Therapies Incorporated | 57.76M | -1.57% | 344,358 | - |
| 403 | RNXT | RenovoRx, Inc. | 57.31M | 3.25% | 226,267 | 1.98M |
| 404 | HYFT | MindWalk Holdings Corp. | 56.53M | -5.51% | 215,654 | 11.57M |
| 405 | GANX | Gain Therapeutics, Inc. | 56.30M | 8.40% | 2,751,162 | - |
| 406 | HRTX | Heron Therapeutics, Inc. | 56.23M | -12.57% | 4,744,496 | 151.18M |
| 407 | BOLD | Boundless Bio, Inc. | 55.50M | - | 114,063 | - |
| 408 | CLNN | Clene Inc. | 55.15M | 3.19% | 124,245 | 197.00K |
| 409 | ALPS | Alps Group Inc | 54.56M | -0.64% | - | 3.74M |
| 410 | PLRX | Pliant Therapeutics, Inc. | 53.58M | -2.31% | 289,801 | - |
| 411 | ELOX | Eloxx Pharmaceuticals, Inc. | 52.96M | -1.35% | 10,351 | - |
| 412 | XLO | Xilio Therapeutics, Inc. | 52.84M | -4.74% | 15,373 | 64.09M |
| 413 | RNTX | Rein Therapeutics Inc. | 51.97M | -3.59% | 305,236 | - |
| 414 | INKT | MiNK Therapeutics, Inc. | 51.34M | -5.27% | 9,824 | - |
| 415 | ELTX | Elicio Therapeutics, Inc. | 50.99M | 16.17% | 515,618 | - |
| 416 | IBIO | iBio, Inc. | 50.42M | -6.67% | 654,774 | 100.00K |
| 417 | ATNM | Actinium Pharmaceuticals, Inc. | 50.31M | 15.94% | 828,818 | 35.09M |
| 418 | HOWL | Werewolf Therapeutics, Inc. | 49.09M | -1.94% | 184,088 | 21.00M |
| 419 | APLM | Apollomics, Inc. | 48.31M | 1.90% | 3,162 | 8.84M |
| 420 | CNTB | Connect Biopharma Holdings Limited | 47.99M | -4.51% | 1,073,282 | 2.95M |
| 421 | KLRS | Kalaris Therapeutics, Inc. | 47.37M | -1.49% | 43,430 | - |
| 422 | LONA | LeonaBio, Inc. | 46.83M | -12.35% | 49,789 | - |
| 423 | ACET | Adicet Bio, Inc. | 46.07M | -4.68% | 156,527 | - |
| 424 | IMA | ImageneBio, Inc. | 45.92M | -0.98% | 6,187 | 800.00K |
| 425 | MREO | Mereo BioPharma Group plc | 45.90M | -1.30% | 383,988 | 500.00K |
| 426 | HYPD | Hyperion DeFi, Inc. | 45.38M | -5.81% | 137,030 | 1.40M |
| 427 | SER | Serina Therapeutics, Inc. | 44.70M | -0.56% | 51,258 | 130.00K |
| 428 | INMB | INmune Bio Inc. | 42.74M | -4.35% | 220,685 | 50.00K |
| 429 | ATHE | Alterity Therapeutics Limited | 42.60M | -10.04% | 53,305 | 2.50M |
| 430 | BMEA | Biomea Fusion, Inc. | 42.40M | -15.23% | 1,957,330 | - |
| 431 | ANVS | Annovis Bio, Inc. | 42.25M | -0.15% | 448,441 | - |
| 432 | GRCE | Grace Therapeutics, Inc. | 40.28M | -3.05% | 97,096 | - |
| 433 | VERU | Veru Inc. | 39.05M | -0.43% | 85,817 | 16.89M |
| 434 | ALDX | Aldeyra Therapeutics, Inc. | 38.93M | -3.73% | 717,821 | - |
| 435 | GRDX | GridAI Technologies Corp. | 38.88M | 12.04% | 103,419 | - |
| 436 | TIL | Instil Bio, Inc. | 38.66M | -1.21% | 84,868 | - |
| 437 | DWTX | Dogwood Therapeutics, Inc. | 38.07M | -4.27% | 64,631 | - |
| 438 | EDSA | Edesa Biotech, Inc. | 37.29M | -3.16% | 22,690 | - |
| 439 | EYPT | EyePoint, Inc. | 36.91M | -0.44% | 12,497,298 | 2.79M |
| 440 | EXOZ | eXoZymes, Inc. | 36.20M | -0.51% | 26,491 | -700.00 |
| 441 | LITS | Lite Strategy, Inc. | 36.18M | -4.03% | 168,960 | - |
| 442 | NNVC | NanoViricides, Inc. | 35.48M | -7.95% | 147,331 | - |
| 443 | CELU | Celularity Inc. | 34.07M | 2.45% | 144,721 | 18.67M |
| 444 | CRVO | CervoMed Inc. | 33.87M | -4.27% | 96,967 | 331.30K |
| 445 | IRLA | IRulya Therapeutics Inc. | 33.39M | -5.33% | 166,049 | - |
| 446 | IBO | Impact BioMedical Inc. | 32.47M | -5.47% | 21,552 | 35.00K |
| 447 | ESLA | Estrella Immunopharma, Inc. | 31.61M | 32.15% | 6,850,988 | - |
| 448 | FLNA | Filana Therapeutics, Inc. | 31.60M | -0.79% | 250,034 | - |
| 449 | EVAX | Evaxion A/S | 30.94M | - | 107,928 | 7.49M |
| 450 | BSEM | BioStem Technologies, Inc. | 30.85M | 1.19% | 49,618 | 34.59M |
| 451 | MGX | Metagenomi Therapeutics, Inc. | 30.83M | -1.45% | 54,263 | 13.56M |
| 452 | ALGS | Aligos Therapeutics, Inc. | 30.10M | -2.82% | 15,250 | 31.52M |
| 453 | BCTX | BriaCell Therapeutics Corp. | 30.00M | -5.28% | 61,661 | - |
| 454 | RNAZ | TransCode Therapeutics, Inc. | 29.04M | 3.31% | 27,964 | - |
| 455 | CVM | CEL-SCI Corporation | 28.32M | -0.62% | 79,353 | - |
| 456 | ABVC | ABVC BioPharma, Inc. | 27.19M | 4.73% | 45,689 | 797.92K |
| 457 | ATOS | Atossa Therapeutics, Inc. | 27.14M | 7.51% | 90,621 | - |
| 458 | IGC | IGC Pharma, Inc. | 25.61M | 2.14% | 180,439 | 1.11M |
| 459 | IMMP | Immutep Limited | 22.75M | -3.35% | 7,531 | 13.79M |
| 460 | CNTX | Context Therapeutics Inc. | 21.65M | 1.82% | 1,587,864 | - |
| 461 | NXTC | NextCure, Inc. | 21.61M | -12.92% | 71,128 | - |
| 462 | MCRB | Seres Therapeutics, Inc. | 21.40M | -7.39% | 132,202 | 1.88M |
| 463 | PLRZ | Polyrizon Ltd. | 21.18M | -5.21% | 3,260 | - |
| 464 | KYNB | Kyntra Bio, Inc. | 21.14M | 0.19% | 9,541 | 4.62M |
| 465 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.26M | 0.50% | 11,128 | - |
| 466 | NEUP | Neuphoria Therapeutics Inc. | 18.83M | - | - | 1.17M |
| 467 | AKTX | Akari Therapeutics, Plc | 18.51M | -7.53% | 20,885 | - |
| 468 | QNTM | Quantum BioPharma Ltd. | 18.36M | -5.42% | 150,361 | - |
| 469 | BYSI | BeyondSpring Inc. | 18.30M | -10.24% | 74,451 | 1.88M |
| 470 | MRKR | Marker Therapeutics, Inc. | 17.84M | -5.31% | 91,561 | 3.55M |
| 471 | COCP | Cocrystal Pharma, Inc. | 17.57M | -3.35% | 17,116 | 330.00K |
| 472 | ATYR | aTyr Pharma, Inc. | 16.67M | -1.33% | 1,039,984 | 190.00K |
| 473 | JSPR | Jasper Therapeutics, Inc. | 16.49M | -1.73% | 72,341 | - |
| 474 | PBM | Psyence Biomedical Ltd. | 15.72M | -8.85% | 57,047 | - |
| 475 | ICU | SeaStar Medical Holding Corporation | 14.99M | -10.09% | 264,856 | 1.71M |
| 476 | GUTS | Fractyl Health, Inc. | 14.99M | -1.74% | 521,670 | 3.00K |
| 477 | KTTA | Pasithea Therapeutics Corp. | 14.88M | -8.73% | 379,120 | - |
| 478 | NCEL | NewcelX Ltd. | 14.79M | -13.22% | 12,193 | - |
| 479 | KPRX | Kiora Pharmaceuticals, Inc. | 14.76M | -0.85% | 870 | 20.00K |
| 480 | TCRX | TScan Therapeutics, Inc. | 14.65M | -3.48% | 300,265 | 7.11M |
| 481 | DYAI | Dyadic International, Inc. | 14.65M | 0.50% | 44,332 | 3.80M |
| 482 | BCDA | BioCardia, Inc. | 14.06M | -5.47% | 50,139 | 3.00K |
| 483 | ALLR | Allarity Therapeutics, Inc. | 13.47M | -3.75% | 90,822 | 345.00K |
| 484 | CNSY | Cerenome, Inc. | 13.28M | 1.16% | 43,136 | 4.20M |
| 485 | TVRD | Tvardi Therapeutics, Inc. | 12.97M | -4.69% | 55,395 | - |
| 486 | DARE | Daré Bioscience, Inc. | 12.82M | -5.28% | 327,899 | 1.37M |
| 487 | HIND | Vyome Holdings, Inc. | 12.63M | -2.17% | 10,868 | 129.73K |
| 488 | PLUR | Pluri Inc. | 12.47M | -3.81% | 9,631 | 1.02M |
| 489 | ACTU | Actuate Therapeutics, Inc. | 12.40M | -8.18% | 334,899 | - |
| 490 | KPTI | Karyopharm Therapeutics Inc. | 12.39M | 28.68% | 7,488,472 | 146.62M |
| 491 | RADX | Radiopharm Theranostics Limited | 12.17M | -2.94% | 15,760 | 8.90M |
| 492 | LPCN | Lipocine Inc. | 12.04M | -8.75% | 354,744 | 1.57M |
| 493 | AEON | AEON Biopharma, Inc. | 11.66M | -2.71% | 113,641 | - |
| 494 | PASG | Passage Bio, Inc. | 11.29M | -2.23% | 43,912 | - |
| 495 | ADIL | Adial Pharmaceuticals, Inc. | 11.08M | 2.68% | 2,266 | - |
| 496 | CLRB | Cellectar Biosciences, Inc. | 11.06M | -8.59% | 68,634 | - |
| 497 | GDTC | CytoMed Therapeutics Limited | 10.97M | - | 5,906 | 609.73K |
| 498 | BLRX | BioLineRx Ltd. | 10.57M | -2.20% | 5,195 | 1.39M |
| 499 | PPBT | Purple Biotech Ltd | 10.49M | -8.70% | 19,534 | - |
| 500 | INTS | Intensity Therapeutics, Inc. | 10.41M | 1.50% | 6,838 | - |